首页> 美国卫生研究院文献>ACR Open Rheumatology >Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III Randomized Controlled Trials

【2h】

Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III Randomized Controlled Trials

机译：治疗性关节炎的长期安全性和可耐受性三期III随机对照试验的合并安全分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Psoriatic arthritis (PsA) requires long‐term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long‐term Assessment of Clinical Efficacy (PALACE) 1, 2, and 3 data describes 3‐year apremilast safety and tolerability in PsA.

机译：银屑病关节炎（PSA）需要长期治疗，但安全问题和监测要求使维护挑战。这种分析对汇集的银屑病关节炎的长期评估临床疗效（宫殿）1,2和3个数据描述了3年度的3年度对3年度的PSA中的可耐受性。

著录项

期刊名称 ACR Open Rheumatology
作者
Philip J. Mease; Dafna D. Gladman; Juan J. Gomez‐Reino; Stephen Hall; Arthur Kavanaugh; Eric Lespessailles; Georg Schett; Maria Paris; Nikolay Delev; Lichen Teng; Jürgen Wollenhaupt;
展开▼
作者单位

展开▼
年(卷),期 2020(2),8
年度 2020
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for >= 156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2) [J] . Crowley Jeffrey, Thaci Diamant, Joly Pascal, Journal of the American Academy of Dermatology . 2017,第2期

机译：牛皮癣患者的长期安全性和可耐受性：汇总安全分析> = 156周，从2期3，随机，对照试验（尊重1和2）
2. Long-term safety and tolerability of apremilast in patients with moderate to severe psoriasis and cardiometabolic comorbidities: Pooled safety analysis for 156 weeks and beyond from phase 3, randomized, controlled trials (ESTEEM) [J] . Cather J., Girolomoni G., Shah K., Experimental dermatology . 2017,第3期

机译：适度至严重牛皮癣和心脏素质合并症患者的长期安全性和可耐受性：156周和超出第3阶段，随机，受控试验（尊重）的合并安全分析
3. Long-term safety and tolerability of apremilast in patients with psoriasis: pooled safety analysis of two phase randomized controlled trials (ESTEEM 1 and 2) [J] . Reich K., Papp K., Gordon K., British Journal of Dermatology . 2014,第6期

机译：银屑病患者的前瞻性长期安全性和耐受性：两阶段随机对照试验（ESTEEM 1和2）的合并安全性分析
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Extended report: Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised double-blind placebo-controlled trials conducted in patients with rheumatoid arthritis psoriatic arthritis or ankylosing spondylitis [O] . Jonathan Kay, Roy Fleischmann, Edward Keystone, -1

机译：扩展报告：戈利木单抗3年安全更新：对风湿性关节炎银屑病关节炎或强直性脊柱炎患者进行的随机双盲安慰剂对照试验的长期扩展收集的数据分析
7. Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2) [O] . Crowley, Jeffrey, Thaçi, Diamant, Joly, Pascal, 2017

机译：银屑病患者的普瑞司特的长期安全性和耐受性：从两项3期随机对照试验（ESTEEM 1和2）开始，进行≥156周的汇总安全性分析

Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III Randomized Controlled Trials

摘要

著录项

相似文献

相关主题

期刊订阅